Navigation Links
Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
Date:9/28/2010

PRINCETON, N.J., Sept. 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Steven R. Johnson as Vice President, Business Development. Mr. Johnson will be responsible for Laureate's worldwide business development activities, including sales, marketing, business development and project management, supporting the company's contract development, protein manufacturing, testing and aseptic filling businesses.

"Steve brings a proven track record of sales management in the biologics market combined with extensive senior relationships," said Michael A. Griffith, Chief Executive Officer of Laureate Pharma.  "He is an industry leader and brings to Laureate Pharma an impressive background that includes broad international business development experience in contract manufacturing of monoclonal antibodies, biopharmaceuticals and chemical active pharmaceutical ingredients."

"Steve is a great fit at Laureate and is well-positioned to take us to the next level with our clients as we prepare to invest in growth of the business," said Mr. Griffith who recently joined Laureate Pharma as Chief Executive Officer and is also a member of the Board of Directors. He was the Founder and Chief Executive Officer of Aptuit, Inc., and the Chairman and Chief Executive Officer of ChiRex, Inc.

Mr. Johnson joins Laureate from Lonza where he served most recently as Vice President Global Business Development, and previously as Vice President, Sales and Business Development, North America. In both positions, Steve supported several of Lonza's contract manufacturing business units, including cell culture protein manufacturing, microbial protein production and stem cell production. Previously, Steve held the position of Vice President, Sales North America for Degussa Fine Chemicals. He began his career as a microbiologist in Merck's Chemical Manufacturing Division and transitioned to roles of increasing responsibility in purchasing, sourcing and business development. Steve earned a B.S. in Microbiology from the University of Illinois and an MBA from James Madison University.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ.  With more than 30 years of experience, Laureate provides the range of services required for the manufacture of monoclonal antibodies and other biopharmaceutical products produced by mammalian cells including cell line development, media optimization, process development, formulation, pilot production, cGMP production for clinical and commercial supply, aseptic fill/finish, and assistance with regulatory support and CMC documentation. Laureate is a portfolio company of Saints Capital, LLC.

About Saints Capital, LLC.

Saints Capital is a leading direct secondary acquirer of venture capital and private equity investments in emerging growth companies around the globe. It also makes traditional direct venture capital investments on a primary basis and in special situations in technology, healthcare, consumer and industrial companies in the United States. Founded in 2000, Saints provides liquidity for private investors in such markets as investment and commercial banks, buyouts, corporate venture capital and hedge funds. Saints has more than $1 billion of committed capital under management, over 50 completed portfolio transactions and investments in more than 200 companies. For more information, please visit www.saintsvc.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
3. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
4. Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
5. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
6. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
7. Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
9. New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format
10. China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores
11. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute lymphocytic Leukemia Market ... to their offering.       (Logo: ... Acute Lymphocytic Leukemia Market and Competitive Landscape ... Lymphocytic Leukemia pipeline products, Acute Lymphocytic Leukemia ...
(Date:5/3/2016)... , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product ... Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... , ... A new collaboration will give more researchers access to the largest ... analytics leader SAS will provide researchers worldwide with data management and analytics tools to ... , The DCRI and SAS share the goal of greater transparency and openness ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, ... same-day LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her ... surgery the same day as her in-office consultation and eye exam. Francesca’s eyesight was ...
(Date:5/4/2016)... ... 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned ... a free seminar on stem cell injections. The seminar is scheduled for Wednesday, May ... Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. , ...
(Date:5/4/2016)... Lenexa, KS (PRWEB) , ... May 04, 2016 ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps ... life-saving treatments to patients. , Since Transtem’s initial launch, Mediware has continued to ...
Breaking Medicine News(10 mins):